Bariatric Surgery Industry - Regional Synopsis
North America Market Analysis
North America is projected to hold the largest share of 48.5% in the bariatric surgery market during the forecast timeline. The leadership of the region is attributable to the rising obesity rates and the expanding insurance coverage. The market grows at 8.4% CAGR, driven by unique developmental approaches undertaken by the U.S. and Canada. CDC study underscores that there are 42.5% adult obesity rates, due to which the Medicare spending is expected to increase by USD 1.3 billion in 2024. Furthermore, 28 states in the region are granting coverage, hence providing an optimistic opportunity for the region’s market.
The U.S. is set to dominate the global bariatric surgery market, comprising a considerable share with a surge in chronic conditions and provision of public healthcare investments. As stated by AHRQ in 2023, robotic-assisted procedures grew by 27%, which is a 14% increase from 2020, reflecting a widespread adoption. Also, the outpatient adoption witnessed an expanded adoption in 40% of cases, further propelling growth in the country. Therefore, the combination of all of these factors significantly enables the prolific opportunity for market development.
There is a tremendous opportunity for the bariatric surgery market in Canada, driven by the enhanced procedural volumes and robust healthcare investments. Ontario extended its support with the allocation of USD 124 million in 2024 to reduce long wait periods, whereas Alberta expanded its coverage to BMI to over 30 with comorbidities. The Canada Institute for Health Information (CIHI) states that the future growth of the sector relies on provincial funding and telemedicine adoption for post-surgical care.
Asia Pacific Market Statistics
Asia Pacific’s bariatric surgery market is poised for the fastest growth, rising at a CAGR of 11.5%, owing to the robust healthcare infrastructure. Each country in the region makes a unique contribution towards the upliftment of the market, thereby positioning Asia Pacific as a critical player in the global merchandise. The growing burden of metabolic disorders, medical tourism, and regulatory support propels business in the sector. Besides the aspect of universal health coverage, and stringent BMI threshold also fosters a favorable business environment in the region.
China dominates the regional bariatric surgery market with 46.7% of the share in the Asia Pacific. The domination of the country caters to the government funding and domestic manufacturing initiatives. As stated by the National Medical Products Administration, over 500,000 bariatric procedures were performed in 2024 and are expected to double by the end of 2037 due to improved healthcare access. Further, the medical tourism contributes to a USD 1.3 billion growth in the private sector, and minimally invasive techniques now account for over 70% of surgeries, supporting market integration in the country.
The India bariatric surgery market is gaining immense exposure with expanded demand and healthcare reforms. It is reported that 1.5 million bariatric procedures were performed in 2024, which is a 300% up from the past few years, reflecting a heightened demand. On the other hand, the government funding reached USD 4.5 billion with a collective focus on tier-2 city hospitals to reduce negative outcomes. Therefore, all of these factors appreciably drive business in this sector, with medical tourism offering 30% of the revenue in the country.
